FOUR GUARDIANS LIFE SCIENCES

Four Guardians Life Sciences is a New Corp. with no liablities only IP & Clinical trial drug assets, as a first stage, we are looking to raise USD 8 million in exchange for convertable notes to convert to equity once the company is formed outside Australia as there is a very small market here. This should be through the issue of up to 32,000,000 fully paid Ordinary Shares at an issue price of USD$0.25 per Share. The IP Licence will also will be transfered into 4G New Corp. in the US. The c... apital we seek is For financing the Mexican Phase II b Evaluation Study of Safety and Efficacy of DG-17 final doses in HIV-Infected Patients and Phase III Evaluation Study of Safety and Efficacy of DG-17 in HIV-Infected Patients with the objective of securing marketing registration approval for a dosage form of finished DG-17 Protease Inhibitor Drug"" and ""For financing initial commercialisation of DG-17 in the Mexican and later the US markets"".

#People #Website #More